Table 2. The sensitivities and specificities of AFB in detection of precancerous lesions.
| Author | System | Sensitivity (%) | Specificity (%) |
|---|---|---|---|
| Häuβinger L. (20) | D-Light | 82.3 | 58.4 |
| Chiyo M. (21) | AFI | 80 | 83.3 |
| Chiyo M. (21) | LIFE | 96.7 | 36.6 |
| Ueno K. (22) | AFI | 94.7 | 71.1 |
| Chhajed P.N. (23) | LIFE | 96 | 23 |
| Lam B. (24) | SAFE-1000 | 91.7 | 26.4 |
| Stringer M.R. (25) | LIFE | 84.4 | 60.7 |
| Hanibuchi M (26) | SAFE-1000 | 96.8 | 56.1 |
| Beamis J.F. (27) | D-Light | 61.2 | 75.3 |
| Ernst A. (28) | D-Light | 66 | 73 |
| Herth F.J.F. (29) | AFI | 65 | 40 |
| Hirsch F.R. (30) | LIFE | 73 | 46 |
| Edell E. (31) | Onco-LIFE | 44 | 75 |
| Cetti EJ (32) | AFI | 93.3 | 81.8 |
| Zaric B (16) | AFI | 79.6 | 52 |
| Divisi D (33) | SAFE 3000 (Twin Mode) | 96 | 60 |
| Divisi D (33) | SAFE 3000 (MIX)’ | 100 | 60 |
| Li Y (34) | AFI | 94.7 | 57 |
| Chen W (18) | Meta-analysis | 90 | 56 |
| Sun J (19) | Meta-analysis | 94.7 | 60.9 |